Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schmiester

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Cell Reports|August 11, 2021
Cell-to-cell variability in JAK2/STAT5 pathway components and cytoplasmic volumes defines survival threshold in erythroid progenitor cellsLorenz Adlung, Paul Stapor, Christian Tönsing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2024
Computational Model Predicts Patient Outcomes in Luminal B Breast Cancer Treated with Endocrine Therapy and CDK4/6 InhibitionLeonard Schmiester, Fara Brasó-Maristany, Blanca González-Farré, et al.
BMC Cancer|January 31, 2020
Combination therapy with Olaratumab/doxorubicin in advanced or metastatic soft tissue sarcoma -a single-Centre experienceJana Käthe Striefler, Franziska Brandes, Alexander Baur, et al.
Cancer Medicine|March 17, 2022
Comorbidities rather than older age define outcome in adult patients with tumors of the Ewing sarcoma familyJana Käthe Striefler, Maren Schmiester, Franziska Brandes, et al.
BMC Palliative Care|January 15, 2021
Impact of a specialised palliative care intervention in patients with advanced soft tissue sarcoma - a single-centre retrospective analysisF Brandes, J K Striefler, A Dörr, et al.
Gut Microbes|May 31, 2022
Flow cytometry can reliably capture gut microbial composition in healthy adults as well as dysbiosis dynamics in patients with aggressive B-cell non-Hodgkin lymphomaMaren Schmiester, René Maier, René Riedel, et al.
Cell Systems|December 4, 2018
Efficient Parameter Estimation Enables the Prediction of Drug Response Using a Mechanistic Pan-Cancer Pathway ModelFabian Fröhlich, Thomas Kessler, Daniel Weindl, et al.
The Journal of Pathology. Clinical Research|November 12, 2020
TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanismsMaren Schmiester, Anna Dolnik, Uwe Kornak, et al.
Bioinformatics (Oxford, England)|November 23, 2023
pyPESTO: a modular and scalable tool for parameter estimation for dynamic modelsYannik Schälte, Fabian Fröhlich, Paul J Jost, et al.
Cell Reports Methods|April 14, 2023
Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening dataAlvaro Köhn-Luque, Even Moa Myklebust, Dagim Shiferaw Tadele, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cell Reports|August 11, 2021
Cell-to-cell variability in JAK2/STAT5 pathway components and cytoplasmic volumes defines survival threshold in erythroid progenitor cellsLorenz Adlung, Paul Stapor, Christian Tönsing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2024
Computational Model Predicts Patient Outcomes in Luminal B Breast Cancer Treated with Endocrine Therapy and CDK4/6 InhibitionLeonard Schmiester, Fara Brasó-Maristany, Blanca González-Farré, et al.
BMC Cancer|January 31, 2020
Combination therapy with Olaratumab/doxorubicin in advanced or metastatic soft tissue sarcoma -a single-Centre experienceJana Käthe Striefler, Franziska Brandes, Alexander Baur, et al.
Cancer Medicine|March 17, 2022
Comorbidities rather than older age define outcome in adult patients with tumors of the Ewing sarcoma familyJana Käthe Striefler, Maren Schmiester, Franziska Brandes, et al.
BMC Palliative Care|January 15, 2021
Impact of a specialised palliative care intervention in patients with advanced soft tissue sarcoma - a single-centre retrospective analysisF Brandes, J K Striefler, A Dörr, et al.
Gut Microbes|May 31, 2022
Flow cytometry can reliably capture gut microbial composition in healthy adults as well as dysbiosis dynamics in patients with aggressive B-cell non-Hodgkin lymphomaMaren Schmiester, René Maier, René Riedel, et al.
Cell Systems|December 4, 2018
Efficient Parameter Estimation Enables the Prediction of Drug Response Using a Mechanistic Pan-Cancer Pathway ModelFabian Fröhlich, Thomas Kessler, Daniel Weindl, et al.
The Journal of Pathology. Clinical Research|November 12, 2020
TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanismsMaren Schmiester, Anna Dolnik, Uwe Kornak, et al.
Bioinformatics (Oxford, England)|November 23, 2023
pyPESTO: a modular and scalable tool for parameter estimation for dynamic modelsYannik Schälte, Fabian Fröhlich, Paul J Jost, et al.
Cell Reports Methods|April 14, 2023
Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening dataAlvaro Köhn-Luque, Even Moa Myklebust, Dagim Shiferaw Tadele, et al.
Pageof 3